Okumura K - Search Results

1

Uno K, Inukai T, Kayagaki N, Goi K, Sato H, Nemoto A, Takahashi K, Kagami K, Yamaguchi N, Yagita H, Okumura K, Koyama-Okazaki T, Suzuki T, Sugita K, Nakazawa S. Uno K, et al. Among authors: okumura k. Blood. 2003 May 1;101(9):3658-67. doi: 10.1182/blood-2002-06-1770. Epub 2002 Dec 27. Blood. 2003. PMID: 12506034 Free article.

2

Resistance of infant leukemia with MLL rearrangement to tumor necrosis factor-related apoptosis-inducing ligand: a possible mechanism for poor sensitivity to antitumor immunity.

Inukai T, Zhang X, Goto M, Hirose K, Uno K, Akahane K, Nemoto A, Goi K, Sato H, Takahashi K, Honna H, Kagami K, Nakamoto K, Yagita H, Okumura K, Koyama-Okazaki T, Nakazawa S, Sugita K. Inukai T, et al. Among authors: okumura k. Leukemia. 2006 Dec;20(12):2119-29. doi: 10.1038/sj.leu.2404429. Epub 2006 Oct 26. Leukemia. 2006. PMID: 17066095

3

Multiple pathways of TWEAK-induced cell death.

Nakayama M, Ishidoh K, Kayagaki N, Kojima Y, Yamaguchi N, Nakano H, Kominami E, Okumura K, Yagita H. Nakayama M, et al. Among authors: okumura k. J Immunol. 2002 Jan 15;168(2):734-43. doi: 10.4049/jimmunol.168.2.734. J Immunol. 2002. PMID: 11777967

4

Critical role for tumor necrosis factor-related apoptosis-inducing ligand in immune surveillance against tumor development.

Takeda K, Smyth MJ, Cretney E, Hayakawa Y, Kayagaki N, Yagita H, Okumura K. Takeda K, et al. Among authors: okumura k. J Exp Med. 2002 Jan 21;195(2):161-9. doi: 10.1084/jem.20011171. J Exp Med. 2002. PMID: 11805143 Free PMC article.

5

Suppression of antibody production by TNF-related apoptosis-inducing ligand (TRAIL).

Kayagaki N, Yamaguchi N, Abe M, Hirose S, Shirai T, Okumura K, Yagita H. Kayagaki N, et al. Among authors: okumura k. Cell Immunol. 2002 Oct;219(2):82-91. doi: 10.1016/s0008-8749(02)00602-0. Cell Immunol. 2002. PMID: 12576026

6

TRAIL and its receptors as targets for cancer therapy.

Yagita H, Takeda K, Hayakawa Y, Smyth MJ, Okumura K. Yagita H, et al. Among authors: okumura k. Cancer Sci. 2004 Oct;95(10):777-83. doi: 10.1111/j.1349-7006.2004.tb02181.x. Cancer Sci. 2004. PMID: 15504243 Free PMC article. Review.

7

Sensitization of human glioblastomas to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) by NF-kappaB inhibitors.

Kasuga C, Ebata T, Kayagaki N, Yagita H, Hishii M, Arai H, Sato K, Okumura K. Kasuga C, et al. Among authors: okumura k. Cancer Sci. 2004 Oct;95(10):840-4. doi: 10.1111/j.1349-7006.2004.tb02191.x. Cancer Sci. 2004. PMID: 15504253 Free PMC article.

8

TRAIL identifies immature natural killer cells in newborn mice and adult mouse liver.

Takeda K, Cretney E, Hayakawa Y, Ota T, Akiba H, Ogasawara K, Yagita H, Kinoshita K, Okumura K, Smyth MJ. Takeda K, et al. Among authors: okumura k. Blood. 2005 Mar 1;105(5):2082-9. doi: 10.1182/blood-2004-08-3262. Epub 2004 Nov 9. Blood. 2005. Retraction in: Blood. 2023 Nov 23;142(21):1848. doi: 10.1182/blood.2023022801 PMID: 15536146 Free article. Retracted.

9

Antitumor effect of locally produced CD95 ligand.

Seino K, Kayagaki N, Okumura K, Yagita H. Seino K, et al. Among authors: okumura k. Nat Med. 1997 Feb;3(2):165-70. doi: 10.1038/nm0297-165. Nat Med. 1997. PMID: 9018234

10

A metalloproteinase inhibitor prevents lethal acute graft-versus-host disease in mice.

Hattori K, Hirano T, Ushiyama C, Miyajima H, Yamakawa N, Ebata T, Wada Y, Ikeda S, Yoshino K, Tateno M, Oshimi K, Kayagaki N, Yagita H, Okumura K. Hattori K, et al. Among authors: okumura k. Blood. 1997 Jul 15;90(2):542-8. Blood. 1997. PMID: 9226153 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,057 results

Search Page

Filters